Research Article

Cancer prevalence, inpatient mortality and its predictors after pericardiocentesis

Volume: 42 Number: 3 October 27, 2020
Cumhuriyet Medical Journal Cover
Cumhuriyet Medical Journal
PDF Download
EN

Cancer prevalence, inpatient mortality and its predictors after pericardiocentesis

Abstract

Objective: Pericardiocentesis is a percutaneous drainage procedure performed in cardiac tamponade or a moderate-large pericardial effusion that does not respond to medical treatment. The prognosis varies according to the etiology of pericardial effusion, and the parameters that can determine the prognosis are unknown. 
In this study, we aimed to find predictors that can determine inpatient mortality in patients who underwent pericardiocentesis and to determine cancer etiology. 
Method: Ninety-one patients who underwent pericardiocentesis due to moderate-large pericardial effusion or pericardial tamponade were evaluated retrospectively. Baseline characteristics of the patients, their cancer diagnosis before and after pericardiocentesis, pericardial effusion cytology, echocardiographic parameters and laboratory parameters in the baseline evaluation were evaluated. The group with inpatient death (n = 14) and the surviving group (n = 77) were compared with each other. 
Results: There was no significant difference between baseline demographic characteristics and echocardiographic parameters when the patients with inpatient mortality and survivors were compared; only patients diagnosed with cancer (p <0.001) and patients with malignant cytology (p = 0.041) were statistically significantly higher in the group with inpatient mortality. When patients with inpatient mortality and survivors were compared in terms of laboratory parameters, aspartate aminotransferase (AST) [55 (27-455), 26 (19-45); p = 0.007, respectively], lactate dehydrogenase (LDH) [527 (438-944), 282 (225-381); p <0.001, respectively], C-reactive protein (CRP) [120.5 (19.8-140.7), 36.5 (8.26-86.15); p = 0.016, respectively], NTproBNP [8964 (7780-9432), 1310 (351-4556); p = 0.049] values were significantly higher in the inpatient mortality group than in the surviving group. The presence of cancer (p = 0.001), AST (p = 0.008), alanine aminotransferase (ALT) (p = 0.013), LDH (p = 0.015), CRP (p = 0.046) parameters were detected to be predictors that can be used to predict inpatient mortality in the univariate logistic regression analysis conducted to determine the predictors that could indicate inpatient mortality. 
Conclusions: Inpatient mortality is high in patients that were detected to have underlying malignancy and pericardial involvement after pericardiocentesis. In the initial evaluation of these patients, simple laboratory tests such as AST, ALT, NTproBNP, LDH, CRP can give an idea about the short-term prognosis of the disease.

Keywords

References

  1. Referans1. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921-64 DOI: 10.1093/eurheartj/ehv318.
  2. Referans2. Strobbe A, Adriaenssens T, Bennett J, Dubois C, Desmet W, McCutcheon K, Van Cleemput J, Sinnaeve PR. Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis. J Am Heart Assoc. 2017;6(12) DOI: 10.1161/jaha.117.007598.
  3. Referans3. Louw VJ, Reuter H, Smedema JP, Katjitae I, Burgess LJ, Doubell AF. Clinical experience with pericardiocentesis and extended drainage in a population with a high prevalence of HIV. Neth Heart J. 2002;10(10):399-406.
  4. Referans4. Saltzman AJ, Paz YE, Rene AG, Green P, Hassanin A, Argenziano MG, Rabbani L, Dangas G. Comparison of surgical pericardial drainage with percutaneous catheter drainage for pericardial effusion. J Invasive Cardiol. 2012;24(11):590-3.
  5. Referans5. Vayre F, Lardoux H, Pezzano M, Bourdarias JP, Dubourg O. Subxiphoid pericardiocentesis guided by contrast two-dimensional echocardiography in cardiac tamponade: experience of 110 consecutive patients. Eur J Echocardiogr. 2000;1(1):66-71 DOI: 10.1053/euje.1999.0003.
  6. Referans6. Sethi A, Singbal Y, Kodumuri V, Prasad V. Inpatient mortality and its predictors after pericardiocentesis: An analysis from the Nationwide Inpatient Sample 2009-2013. J Interv Cardiol. 2018;31(6):815-25 DOI: 10.1111/joic.12563.
  7. Referans7. Kim SH, Kwak MH, Park S, Kim HJ, Lee HS, Kim MS, Lee JM, Zo JI, Ro JS, Lee JS. Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat. 2010;42(4):210-6 DOI: 10.4143/crt.2010.42.4.210.
  8. Referans8. Jama GM, Scarci M, Bowden J, Marciniak SJ. Palliative treatment for symptomatic malignant pericardial effusion†. Interact Cardiovasc Thorac Surg. 2014;19(6):1019-26 DOI: 10.1093/icvts/ivu267.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Authors

Emin Koyun
0000-0001-9823-1613
Türkiye

Publication Date

October 27, 2020

Submission Date

August 20, 2020

Acceptance Date

September 18, 2020

Published in Issue

Year 2020 Volume: 42 Number: 3

DOI

https://doi.org/10.7197/cmj.vi.782892

IZ

https://izlik.org/JA33YU42DZ

Cite

RIS / Bibtex
AMA
1.Çerik İB, Dindaş F, Koyun E, Gül İ. Cancer prevalence, inpatient mortality and its predictors after pericardiocentesis. CMJ. 2020;42(3):311-318. doi:10.7197/cmj.vi.782892